Know Cancer

or
forgot password

LED Photomodulation for Prevention of Post-Radiation Treatment Dermatitis: A Prospective, Randomized, Controlled Study


N/A
18 Years
N/A
Not Enrolling
Both
Radiation Dermatitis

Thank you

Trial Information

LED Photomodulation for Prevention of Post-Radiation Treatment Dermatitis: A Prospective, Randomized, Controlled Study


Inclusion Criteria:



- Subjects must have clinically diagnosed breast or head and neck cancer that will be
treated with radiation therapy.

- Subjects must be at least 18 years of age

Exclusion Criteria:

- Subjects will not be eligible to participate if they are pregnant or lactating.

- Patients treated with partial breast irradiation techniques, brachytherapy, or other
non-standard techniques will not be eligible.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention

Outcome Measure:

Determine efficacy

Outcome Time Frame:

6 years

Safety Issue:

Yes

Principal Investigator

Douglas Fife, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Chao Family Comprehensive Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

UCI 06-46

NCT ID:

NCT00573365

Start Date:

March 2007

Completion Date:

August 2008

Related Keywords:

  • Radiation Dermatitis
  • dermatitis
  • skin
  • radiation
  • light
  • LED photomodulation
  • Gentlewaves
  • Dermatitis
  • Radiodermatitis

Name

Location

Chao Family Comprehensive Cancer CenterOrange, California  92868